Consequently, upregulation of SGLT2 protein levels in osteosarcoma may be linked to diminished degradation of SGLT2 facilitated by TRIM21(Wu et al., 2022). STING mRNA and protein levels were upregulated in response to SGLT-2i in a dose-dependent manner. This evidence concerns the gene STING1 and osteosarcoma.